Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2016-04-27 Capital/Financing Update
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2016
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC by Medpace Holdings, Inc. It is a preliminary prospectus related to an initial public offering (IPO) of common stock. The text includes detailed information about the offering, risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business description, management, executive compensation, principal shareholders, and legal matters. This type of filing is a registration statement for securities offering, not a financial report, earnings release, or other types of filings. The Form S-1 and its amendments are related to capital raising and securities registration, which falls under Capital/Financing Update filings. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing. Confidence is high given the clear identification of the form and content.
2016-04-27 English
Regulatory Filings 2016
Regulatory Filings
2016-04-12 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a letter dated March 15, 2016, from legal counsel submitting a confidential draft registration statement on Form S-1 to the SEC for non-public review prior to public filing. It references the Jumpstart Our Business Startups Act and is clearly a submission related to an initial registration for securities offering. The document is short (1571 characters) and is a cover letter for a confidential submission, not the registration statement itself. Therefore, it is not a financial report or filing like an Annual Report or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a regulatory submission document that does not fit other specific categories.
2016-03-15 English
Capital/Financing Update 2016
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC, related to an initial public offering (IPO) of Medpace Holdings, Inc. It includes a preliminary prospectus with detailed information about the offering, risk factors, use of proceeds, capitalization, dilution, financial data, management discussion and analysis, business description, management, executive compensation, principal shareholders, and legal matters. The document is a registration statement under the Securities Act of 1933, which is a filing used to register securities for public sale. This type of document is not an annual report, earnings release, or any other financial report but a capital markets filing related to the company's IPO and securities registration. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Since this is an IPO registration statement, it is best classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not an RPA or RNS. Therefore, the appropriate classification is CAP with high confidence.
2016-03-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.